Risk Factors for Olfactory Dysfunction in Hospital Setting Following Covid-19 Infection Among Hospital Employees Following Treatment of Covid-19 Infected Patients: A Survey Research

Dolly Irfandy; Afriwardi Afriwardi; Bestari J. Budiman; Andani E. Putra; Dwitya Elvira; Claudia Triananda

doi:10.55681/sentri.v4i7.4272

Authors

Dolly Irfandy Universitas Andalas
Afriwardi Afriwardi Universitas Andalas
Bestari J. Budiman Universitas Andalas
Andani E. Putra Universitas Andalas
Dwitya Elvira Universitas Andalas
Claudia Triananda Universitas Andalas

DOI:

https://doi.org/10.55681/sentri.v4i7.4272

Keywords:

COVID-19, smoke, obesity, olfactory dysfunction, resident doctors, hospital employee

Abstract

Coronavirus disease 2019 (COVID-19) is an infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To reveal the risk factors for olfactory dysfunction in employees with COVID-19 in the workplace of the subject hospital in Indonesia. This study was quantitative and descriptive, using data from questionnaires distributed to subject hospital in Indonesia employees who have experienced COVID-19. This study shows that anosmia (33.2%) is the most common olfactory dysfunction in COVID-19. COVID-19 infection often occurs in resident doctors (58.1%); women (55.6%); those aged 55 years (92.3%); those with comorbidities such as hypertension (4.3%) and obesity (65%); nonsmokers (91.5%) and smokers 10–20 cigarettes per day (5.1%); and nondrinkers (100%). Anosmia is the most common olfactory dysfunction in COVID-19. It is commonly experienced by resident doctors, women aged ≥55 years, employees without comorbidities, obese employees, nonsmokers, and nondrinker

Downloads

Download data is not yet available.

References

Nile SH, Nile A, Qiu J, Li L, Jia X, Kai G. COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons. Cytokine Growth Factor Rev. 2020;53:66-70.

Samuel I, Wreksoatmodjo BR. Anosmia pada COVID-19 [Anosmia in COVID-19]. Cermin Dunia Kedokteran. 2021;48(1):25-29.

Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol. 2020;92(4):418-423.

Kementerian Kesehatan RI. Situasi terkini perkembangan coronavirus disease (COVID-19) [Current situation regarding the development of coronavirus disease (COVID-19)]. 2022. https://infeksiemerging.kemkes.go.id/situasi-infeksi-emerging/situasi-terkini-perkembangan-coronavirus-disease-covid-19-17-april-2022

Pemerintah Provinsi Sumatera Barat. Data pantuan COVID-19 Provinsi Sumatera Barat [COVID-19 monitoring data for West Sumatra Province]. 2022. https://corona.sumbarprov.go.id/web

Susilo A, Rumende CM, Pitoyo CW, Santoso WD, Yulianti M, Herikurniawan H, et al. Coronavirus disease 2019: Tinjauan literatur terkini [Coronavirus disease 2019: A review of the current literature]. J Penyakit Dalam Indones. 2020;7(1):45-67.

Ulfah S, Candi C, Darmawan ES. Risk factors of Covid-19 transmission between hospital employees. Childhood Stunting, Wasting, and Obesity, as the Critical Global Health Issues: Forging Cross-Sectoral Solutions. 2020:30-35.

Ge H, Wang X, Yuan X, Xiao G, Wang C, Deng T, et al. The epidemiology and clinical information about COVID-19. Eur J Clin Microbiol Infect Dis. 2020;39(6):1011-1019.

Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): A multicenter European study. Eur Arch Otorhinolaryngol. 2020;277(8):2251-2261.

Poerbonegoro NL, Reksodiputro MH, Sari DP, Mufida T, Rahman MA, Reksodiputro LA, et al. Cross-sectional study on the proportion of smell and taste disturbances in hospitalized COVID-19 patients. Ann Med Surg. 2021;71:102909.

Schäfer L, Schriever VA, Croy I. Human olfactory dysfunction: Causes and consequences. Cell Tissue Res. 2021;383(1):569-579.

Klopfenstein T, Zahra H, Kadiane-Oussou NJ, Lepiller Q, Royer P-Y, Toko L, et al. New loss of smell and taste: Uncommon symptoms in COVID-19 patients on Nord Franche-Comte cluster, France. Int J Infect Dis. 2020;100:117-122.

Bax F, Tascini C, Valente M, Marini A, Surcinelli A, Pellitteri G, De Carlo C, Gerussi V, Gigli GL. Hyposmia and dysgeusia in COVID-19: Indication to swab test and clue of CNS involvement. Neurol Clin Pract. 2021;11(2):92-96.

Otoum MM, Obeidat MB, Yamin HY, Al Husban WAK, Alkhlaifat AM. The prevalence of anosmia in COVID-19 patients and the associated factors. Sch J Appl Med Sci. 2022;10(2):245-247.

Hasan MM, Tamanna NA, Jamal MN, Uddin MJ. The prevalence of olfactory dysfunction and its associated factors in patients with COVID-19 infection. medRxiv. 2021;3-9.

Friske MM, Giannone F, Senger M, Seitz R, Hansson AC, Spanagel R. Chronic alcohol intake regulates expression of SARS-CoV2 infection-relevant genes in an organ-specific manner. bioRxiv. 2022;3-22.

Zhao Y, Liu Y, Yi F, Zhang J, Xu Z, Liu Y, Tao Y. Type 2 diabetes mellitus impaired nasal immunity and increased the risk of hyposmia in COVID-19 mild pneumonia patients. Int Immunopharmacol. 2021;93:107406.

Najafloo R, Majidi J, Asghari A, Aleemardani M, Kamrava SK, Simorgh S, Seifalian A, Bagher Z, Seifalian AM. Mechanism of anosmia caused by symptoms of COVID-19 and emerging treatments. ACS Chem Neurosci. 2021;12(20):3795-3805.

Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):259-260.

Dahlan MS. Besar sampel dan cara pengambilan sampel dalam penelitian kedokteran dan kesehatan [Sample size and sampling methods in medical and health research]. Salemba Medika. 2010;29.

Fenólio GHM, Anselmo-Lima WT, Tomazini GC, Compagnoni IM, Amaral MSA, Fantucci MZ, Peixoto PPL, Guimarães AF, Guimarães RES, Sakano E, Valera FCP, Tamashiro E. Validation of the connecticut olfactory test (CCCRC) adapted to Brazil. Braz J Otorhinolaryngol. 2022;88:725-732.

Mubaraki AA, Alrbaiai GT, Sibyani AK, Alhulayfi RM, Alzaidi RS, Almalki HS. Prevalence of anosmia among COVID-19 patients in Taif City, Kingdom of Saudi Arabia. Saudi Med J. 2021;42(1):38-43.

Butowt R, Von Bartheld CS. Anosmia in COVID-19: Underlying mechanisms and assessment of an olfactory route to brain infection. Neuroscientist. 2021;27(6):582-603.

Mercier J, Osman M, Bouiller K, Tipirdamaz C, Gendrin V, Chirouze C, Lepiller Q, Bouvier E, Royer P, Pierron A, Toko L, Plantin J, Kadiane-Oussou N, Zayet S, Klopfenstein T. Olfactory dysfunction in COVID-19, new insights from a cohort of 353 patients: The ANOSVID study. J Med Virol. 2022;94(10):4762-4775.

Mercante G, Ferreli F, De Virgilio A, Gaino F, Di Bari M, Colombo G, Russo E, Costantino A, Pirola F, Cugini G, Malvezzi L, Morenghi E, Azzolini E, Lagioia M, Spriano G. Prevalence of taste and smell dysfunction in coronavirus disease 2019. JAMA Otolaryngol Head Neck Surg. 2020;146(8):723-728.

Mendonça CV, Mendes Neto JA, Suzuki FA, Orth MS, Machado Neto H, Nacif SR. Olfactory dysfunction in COVID-19: A marker of good prognosis? Braz J Otorhinolaryngol. 2022;88(3):439-444.

Printza A, Katotomichelakis M, Valsamidis K, Metallidis S, Panagopoulos P, Panopoulou M, Petrakis V, Constantinidis J. Smell and taste loss recovery time in COVID-19 patients and disease severity. J Clin Med. 2021;10(5):966.

Hüttenbrink KB, Hummel T, Berg D, Gasser T, Hähner A. Olfactory Dysfunction. Dtsch Arztebl Int. 2013;110(1-2):1-5.

Irfandy D, Budiman BJ, Huryati E. Relationship between deviations of nasal septum and mucociliary transport time using saccharin test. Otorinolaringologia. 2019;69(1):30-35.

Villarreal IM, Morato M, Martínez-RuizCoello M, Navarro A, Garcia-Chillerón R, Ruiz Á, De Almeida IV, Mazón L, Plaza G. Olfactory and taste disorders in healthcare workers with COVID-19 infection. Eur Arch Otorhinolaryngol. 2021;278(6):2123-2127.

Adelina M, Dwijayanti F. The infection of COVID-19 among health care workers in Dharmais Cancer Hospital. Indones J Cancer. 2021;15(1):1-2.

Jha S, Singh RK, Kumar S, Singh T. Institutional evaluation of anosmia and ageusia in COVID-19 positive health care workers of clinical and non-clinical departments. Int J Res Med Sci. 2022;10(3):683-686.

Awwad AA, Abd Elhay OM, Rabie MM, Awad EA, Kotb FM, Maghraby HM, Eldamarawy RH, Dawood YM, Balat MI, Hasan AI, Elsheshiny AH, El Sayed SS, Fouda AA, Alkot AM. Impact of systemic diseases on olfactory function in COVID-19 infected patients. Int J Gen Med. 2022;15:5681-5691.

Lechien JR, Chiesa-Estomba CM, Vaira LA, De Riu G, Cammaroto G, Chekkoury-Idrissi Y, Circiu M, Distinguin L, Journe F, De Terwangne C, Machayekhi S, Barillari MR, Calvo-Henriquez C, Hans S, Saussez S. Epidemiological, otolaryngological, olfactory and gustatory outcomes according to the severity of COVID-19: A study of 2579 patients. Eur Arch Otorhinolaryngol. 2021;278(8):2851-2859.

Talavera B, García-Azorín D, Martínez-Pías E, Trigo J, Hernández-Pérez I, Valle-Peñacoba G, Simón-Campo P, De Lera M, Chavarría-Miranda A, López-Sanz C, Gutiérrez-Sánchez M, Martínez-Velasco E, Pedraza M, Sierra Á, Gómez-Vicente B, Guerrero Á, Arenillas JF. Anosmia is associated with lower in-hospital mortality in COVID-19. J Neurol Sci. 2020;419:117163.

Klopfenstein T, Kadiane-Oussou NJ, Toko L, Royer PY, Lepiller Q, Gendrin V, Zayet S. Features of anosmia in COVID-19. Med Mal Infect. 2020;50(5):436-439.

Khan AS, Hichami A, Khan NA. Obesity and COVID-19: Oro-naso-sensory perception. J Clin Med. 2020;9(7):2158.

Paderno A, Schreiber A, Grammatica A, Raffetti E, Tomasoni M, Gualtieri T, Taboni S, Zorzi S, Lombardi D, Deganello A, Redaelli De Zinis LO, Maroldi R, Mattavelli D. Smell and taste alterations in COVID‐19: A cross‐sectional analysis of different cohorts. Int Forum Allergy Rhinol. 2020;10(8):955-962.

Neta FI, Fernandes ACL, Vale AJM, Pinheiro FI, Cobucci RN, Azevedo EP, Guzen FP. Pathophysiology and possible treatments for olfactory-gustatory disorders in patients affected by COVID-19. Curr Res Pharmacol Drug Discov. 2021;2:100035.

Mahali M, Coolidge FL. On the relationship between neurocognitive measures and olfactory dysfunction in COVID-19 patients with and without anosmia. Brain Behav Immun Health. 2023;30:100632.